Ally Bridge Group (Ny) LLC Nautilus Biotechnology, Inc. Transaction History

Ally Bridge Group (Ny) LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.55 - $2.47 $1.03 Million - $1.64 Million	-664,742 Reduced 80.68%	159,232 $286,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.13 $502,920 - $803,132	-256,592 Reduced 23.75%	823,974 $1.75 Million
Q1 2022 May 16, 2022	SELL	$3.5 - $5.3 $505,729 - $765,818	-144,494 Reduced 11.79%	1,080,566 $4.69 Million
Q4 2021 Feb 14, 2022	SELL	$4.45 - $6.21 $1.22 Million - $1.71 Million	-274,940 Reduced 18.33%	1,225,060 $6.35 Million
Q2 2021 Aug 16, 2021	BUY	$9.04 - $14.19 $13.6 Million - $21.3 Million	1,500,000 New	1,500,000 $15.2 Million

64.3M

1.9K

100

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $287M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.